Julian Robertson's position in Adaptive Biotechnologies is currently worth $6.61 Million. That's 2.18% of their equity portfolio (11th largest holding). Julian Robertson started to build up the position in Adaptive Biotechnologies in Q3 2019. Since then they sold 526 Thousand shares. The investor's estimated purchase price is $24.1 Million, resulting in a loss of 73%.